Scientists have discovered a gene-editing technology that could efficiently and accurately correct the genetic defects that underlie certain diseases, positioning the new tool as the basis for the next generation of genetic therapies. This editing platform may be used to cure inherited and acquired diseases. The proof-of-concept study spotlights a promising new gene-editing platform that may eventually be used to treat diseases such as sickle cell disease, hemophilia and other genetic disorders.